Adcytherix: Funding, Investors & Team (Sep 2026)
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).
Adcytherix has raised $122M across 1 funding round on record, the most recent a Series A of $122M announced in Oct 2025.
That round is above the $21M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Adcytherix Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Adcytherix Funding Rounds
Adcytherix Founders and Leadership Team
Contact details for the Adcytherix team: 1 of 2 have an email address on file.
Start 14-day free trial →Adcytherix Funding Compared to Other Biotechnology Startups
Adcytherix's latest round of $122M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Adcytherix in Biotechnology and Marseille
Companies Similar to Adcytherix
Tafalgie Therapeutics is a CNRS and AMU spin-off company engaged in biopharmaceutical research.
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other…
Ollin Biosciences operates as a clinical-stage biopharmaceutical company.
Dayra Therapeutics manufactures peptide based medicines.
4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment…
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and…
Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary…
Brise Pharma operates in the scientific research and technical service industry.
Vybio is a high-tech enterprise focusing on innovative drug research and development.
Chirality Biosciences is a developer of chiral molecule separation technology enabling faster, safer, and…
Bexorg provides a technology platform for central nervous system drug discovery and development.
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
Adcytherix Funding FAQs
What does Adcytherix do?
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).
How much funding has Adcytherix raised?
Adcytherix has raised $122M across 1 round on record. The most recent is a Series A of $122M announced in Oct 2025.
When did Adcytherix last raise funding?
Adcytherix's most recent funding round on record is a Series A of $122M, announced in Oct 2025.
Who founded Adcytherix?
FundedIQ lists Carsten Dehning (Founder) at Adcytherix.
Who is the CEO of Adcytherix?
Jack Elands is listed as CEO at Adcytherix.
Where is Adcytherix headquartered?
Adcytherix is based in Marseille, France.
How many employees does Adcytherix have?
Adcytherix is in the 11-50 employee band.
How does Adcytherix's funding compare to other Biotechnology startups?
Adcytherix's latest round of $122M is above the $21M median round size for Biotechnology companies on FundedIQ across 29 tracked companies over the last two years.
About FundedIQ's Adcytherix Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Adcytherix is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.